Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dare Bioscience, Inc. - Common Stock (NQ: DARE )

3.315 -0.015 (-0.45%)
Streaming Delayed Price Updated: 12:11 PM EST, Jan 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,585
Open 3.330
Bid (Size) 3.280 (6)
Ask (Size) 3.350 (61)
Prev. Close 3.330
Today's Range 3.281 - 3.370
52wk Range 2.670 - 7.560
Shares Outstanding 70,521,979
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For November 14, 2024
Via Benzinga
Insights into Dare Bioscience's Upcoming Earnings
Via Benzinga

Performance

YTD
+2.95%
+2.95%
1 Month
+3.92%
+3.92%
3 Month
-10.65%
-10.65%
6 Month
-8.93%
-8.93%
1 Year
-11.23%
-11.23%

More News

Read More
DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Via Benzinga
Recap: Dare Bioscience Q4 Earnings
Via Benzinga
Dare Bioscience Earnings Preview
Via Benzinga
Earnings Outlook For Dare Bioscience
Via Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
Via Benzinga
Earnings Scheduled For March 28, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.